Keros Therapeutics Inc (KROS)

$48.38 0.36 (0.75%)
16:00 EDT KROS Stock Quote Delayed 30 Minutes

KROS Stock Earnings: Keros Therapeutics Beats EPS for Q1 2024

KROS stock results show that Keros Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 1.13B
PE Ratio -9.39
EPS -5.15
Volume (Avg. Vol.) 185,436
Day's Range $46.62 - $48.65
52-Week Range $27.02 - $73.00
Dividend & Yield N/A (N/A)